Evidence based on recent studies Initially, cases of intestinal obstruction associated with GLP-1 RAs were reported by the European Medicines Agency (EMA) in 2013 [9], and this safety signal is currently being monitored by the United States (US) FDA
It deserves emphasis that to date there is no rigorous evidence for a programmed neurotoxic astrocyte phenotype that is somehow activated in a common manner across multiple disorders and represents a universal target, in spite of certain claims to this effect
The relationship between tirzepatide and B12 has received particular attention, as has semaglutide combined with B12
The lyophilisate is dissolved with bacteriostatic water introduced on the inside wall of the vial, without a violent jet onto the powder and without vigorous shaking see Reconstitution Protocol section above for detailed procedure
Challenges such as solubility limitations and non-specific binding must be carefully managed
Nature medicine , 31(3), 951962